Daniel Arias
Stock Analyst at Stifel
(4.70)
# 199
Out of 4,412 analysts
85
Total ratings
64.29%
Success rate
19.7%
Average return
Main Sectors:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Upgrades: Buy | $145 → $163 | $137.74 | +18.34% | 11 | Apr 5, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $11 → $10 | $7.70 | +29.87% | 2 | Feb 23, 2024 | |
| RGEN Repligen | Maintains: Buy | $165 → $207 | $166.58 | +24.26% | 6 | Feb 22, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $68 → $63 | $27.59 | +128.34% | 3 | Feb 16, 2024 | |
| BRKR Bruker | Maintains: Hold | $63 → $81 | $80.97 | +0.04% | 2 | Feb 14, 2024 | |
| WAT Waters | Maintains: Hold | $290 → $330 | $311.30 | +6.01% | 9 | Feb 7, 2024 | |
| RVTY Revvity | Maintains: Hold | $95 → $110 | $101.51 | +8.36% | 1 | Feb 2, 2024 | |
| TECH Bio-Techne | Downgrades: Hold | $65 | $64.06 | +1.47% | 8 | Feb 2, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,425 → $1,270 | $1,238.09 | +2.58% | 3 | Nov 13, 2023 | |
| TMO Thermo Fisher | Maintains: Buy | $660 → $530 | $573.60 | -7.60% | 9 | Oct 26, 2023 | |
| ILMN Illumina | Reiterates: Buy | $200 | $122.28 | +63.56% | 12 | Oct 12, 2023 | |
| CDXS Codexis | Maintains: Buy | $9 → $5 | $2.66 | +87.97% | 2 | Aug 14, 2023 | |
| DHR Danaher | Maintains: Hold | $250 → $240 | $246.58 | -2.67% | 3 | Jul 26, 2023 | |
| EXAS Exact Sciences | Reiterates: Buy | $85 | $58.85 | +44.44% | 3 | Jun 21, 2023 | |
| RNLX Renalytix | Maintains: Buy | $17 → $7 | $0.63 | +1,013.23% | 2 | Jul 1, 2022 | |
| ABSI Absci | Maintains: Hold | $28 → $10 | $4.58 | +118.34% | 2 | May 31, 2022 | |
| AVTR Avantor | Maintains: Buy | n/a | $23.94 | - | 3 | Sep 10, 2021 | |
| MXCT MaxCyte | Initiates: Buy | n/a | $3.71 | - | 1 | Aug 24, 2021 | |
| MASS 908 Devices | Initiates: Buy | n/a | $5.67 | - | 1 | Jan 12, 2021 | |
| QGEN Qiagen | Maintains: Hold | $34 → $41 | $41.65 | -1.08% | 2 | Apr 2, 2020 |
Agilent Technologies
Apr 5, 2024
Upgrades: Buy
Price Target: $145 → $163
Current: $137.74
Upside: +18.34%
Maravai LifeSciences Holdings
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $7.70
Upside: +29.87%
Repligen
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $166.58
Upside: +24.26%
10x Genomics
Feb 16, 2024
Maintains: Buy
Price Target: $68 → $63
Current: $27.59
Upside: +128.34%
Bruker
Feb 14, 2024
Maintains: Hold
Price Target: $63 → $81
Current: $80.97
Upside: +0.04%
Waters
Feb 7, 2024
Maintains: Hold
Price Target: $290 → $330
Current: $311.30
Upside: +6.01%
Revvity
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $101.51
Upside: +8.36%
Bio-Techne
Feb 2, 2024
Downgrades: Hold
Price Target: $65
Current: $64.06
Upside: +1.47%
Mettler-Toledo International
Nov 13, 2023
Maintains: Buy
Price Target: $1,425 → $1,270
Current: $1,238.09
Upside: +2.58%
Thermo Fisher
Oct 26, 2023
Maintains: Buy
Price Target: $660 → $530
Current: $573.60
Upside: -7.60%
Illumina
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $122.28
Upside: +63.56%
Codexis
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.66
Upside: +87.97%
Danaher
Jul 26, 2023
Maintains: Hold
Price Target: $250 → $240
Current: $246.58
Upside: -2.67%
Exact Sciences
Jun 21, 2023
Reiterates: Buy
Price Target: $85
Current: $58.85
Upside: +44.44%
Renalytix
Jul 1, 2022
Maintains: Buy
Price Target: $17 → $7
Current: $0.63
Upside: +1,013.23%
Absci
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $4.58
Upside: +118.34%
Avantor
Sep 10, 2021
Maintains: Buy
Price Target: n/a
Current: $23.94
Upside: -
MaxCyte
Aug 24, 2021
Initiates: Buy
Price Target: n/a
Current: $3.71
Upside: -
908 Devices
Jan 12, 2021
Initiates: Buy
Price Target: n/a
Current: $5.67
Upside: -
Qiagen
Apr 2, 2020
Maintains: Hold
Price Target: $34 → $41
Current: $41.65
Upside: -1.08%